​

Kodiak Sciences (KOD) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

KOD Stock Forecast

Kodiak Sciences (KOD) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $29.67, with a high of $114.00 and a low of $2.00. This represents a 260.07% increase from the last price of $8.24.

- $30 $60 $90 $120 $150 High: $114 Avg: $29.67 Low: $2 Last Closed Price: $8.24

KOD Stock Rating

Kodiak Sciences stock's rating consensus is Buy, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (50.00%), 6 Hold (33.33%), 3 Sell (16.67%), and 0 Strong Sell (0.00%).

Buy
Total 18 0 3 6 9 Strong Sell Sell Hold Buy Strong Buy

KOD Price Target Upside V Benchmarks

TypeNameUpside
StockKodiak Sciences260.07%
SectorHealthcare Stocks 18.80%
IndustryBiotech Stocks 54.28%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$11.00
Last Closing Price$8.24$8.24$8.24
Upside/Downside--33.50%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25-11-35
Jun, 25-12-36
May, 25-12-36
Apr, 25-22-37
Mar, 25-23-38
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 09, 2024Michael YeeJefferies$20.00$11.4874.22%142.72%
Sep 24, 2024Andrea TanGoldman Sachs$2.00$2.43-17.70%-75.73%
Nov 14, 2022Morgan Stanley$9.00$7.5918.58%9.22%
Nov 10, 2022Goldman Sachs$8.00$7.2210.80%-2.91%
Aug 15, 2022Morgan Stanley$12.00$11.732.30%45.63%
Aug 10, 2022Chardan Capital$18.00$11.8452.03%118.45%
Aug 09, 2022Truist Financial$15.00$11.1334.77%82.04%
Aug 09, 2022Goldman Sachs$9.00$11.55-22.08%9.22%
May 24, 2022Goldman Sachs$5.00$6.55-23.66%-39.32%
May 11, 2022Goldman Sachs$7.00$5.2034.62%-15.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 24, 2024Goldman SachsSellSellhold
Sep 05, 2024H.C. WainwrightNeutralinitialise
Apr 04, 2024UBSNeutralNeutralhold
Apr 01, 2024BarclaysUnderweightUnderweighthold
Jul 24, 2023Raymond JamesOutperforminitialise
Nov 14, 2022Morgan StanleyEqual-WeightEqual-Weighthold
Aug 15, 2022Morgan StanleyEqual-WeightEqual-Weighthold
Aug 10, 2022Chardan CapitalBuyBuyhold
Aug 09, 2022Goldman SachsNeutralNeutralhold
May 17, 2022Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.91$-4.97$-3.35----
Avg Forecast$-2.35$-4.60$-3.39$-3.84$-3.72$-4.07$-2.73
High Forecast$-2.35$-4.45$-3.24$-3.00$-3.72$-4.07$-2.73
Low Forecast$-2.35$-4.70$-3.66$-4.39$-3.72$-4.07$-2.73
Surprise %23.83%8.04%-1.18%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$17.86M-$62.02M$602.25K$11.32M$44.66M$138.13M
High Forecast$17.86M-$62.02M$602.25K$11.32M$44.66M$138.13M
Low Forecast$17.86M-$62.02M$602.25K$11.32M$44.66M$138.13M
Surprise %-------

Net Income Forecast

$-300M $-260M $-220M $-180M $-140M $-100M Dec 20 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-133.10M$-260.49M$-176.21M----
Avg Forecast$-123.39M$-239.88M$-180.73M$-193.66M$-194.98M$-213.33M$-143.09M
High Forecast$-123.39M$-233.17M$-169.64M$-157.03M$-194.98M$-213.33M$-143.09M
Low Forecast$-123.39M$-246.59M$-191.81M$-230.28M$-194.98M$-213.33M$-143.09M
Surprise %7.87%8.59%-2.50%----

KOD Forecast FAQ

Is Kodiak Sciences stock a buy?

Kodiak Sciences stock has a consensus rating of Buy, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 6 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Kodiak Sciences is a favorable investment for most analysts.

What is Kodiak Sciences's price target?

Kodiak Sciences's price target, set by 18 Wall Street analysts, averages $29.67 over the next 12 months. The price target range spans from $2 at the low end to $114 at the high end, suggesting a potential 260.07% change from the previous closing price of $8.24.

How does Kodiak Sciences stock forecast compare to its benchmarks?

Kodiak Sciences's stock forecast shows a 260.07% upside, outperforming the average forecast for the healthcare stocks sector (18.80%) and outperforming the biotech stocks industry (54.28%).

What is the breakdown of analyst ratings for Kodiak Sciences over the past three months?

  • July 2025: 0% Strong Buy, 20.00% Buy, 20.00% Hold, 0% Sell, 60.00% Strong Sell.
  • June 2025: 0% Strong Buy, 16.67% Buy, 33.33% Hold, 0% Sell, 50.00% Strong Sell.
  • May 2025: 0% Strong Buy, 16.67% Buy, 33.33% Hold, 0% Sell, 50.00% Strong Sell.

What is Kodiak Sciences’s EPS forecast?

Kodiak Sciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-3.84, marking a 14.63% increase from the reported $-3.35 in 2024. Estimates for the following years are $-3.72 in 2026, $-4.07 in 2027, and $-2.73 in 2028.

What is Kodiak Sciences’s revenue forecast?

Kodiak Sciences's average annual revenue forecast for its fiscal year ending in December 2025 is $602.25K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $11.32M, followed by $44.66M for 2027, and $138.13M for 2028.

What is Kodiak Sciences’s net income forecast?

Kodiak Sciences's net income forecast for the fiscal year ending in December 2025 stands at $-194M, representing an 9.90% increase from the reported $-176M in 2024. Projections indicate $-195M in 2026, $-213M in 2027, and $-143M in 2028.